John Segreti to Dose-Response Relationship, Drug
This is a "connection" page, showing publications John Segreti has written about Dose-Response Relationship, Drug.
Connection Strength
0.066
-
In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile. Diagn Microbiol Infect Dis. 1993 Aug-Sep; 17(2):177-9.
Score: 0.027
-
High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011 Jun; 31(6):527-36.
Score: 0.023
-
Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Relat Res. 2005 Aug; (437):97-104.
Score: 0.016